Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,189,870
-$102,508 QoQ
Shares Held
9,418
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#999
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. GILD ranks #3 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,605 | $1,677,471 | |
| 2 | LLY |
ELI LILLY & Co
|
1,368 | $1,640,820 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
9,418 | $1,189,870 | |
| 4 | AMGN |
Amgen Inc
|
389 | $140,864 | |
| 5 | MRK |
Merck & Co., Inc.
|
899 | $115,521 | |
| 6 | ABBV |
AbbVie Inc.
|
220 | $55,360 | |
| 7 | NVS |
Novartis AG
|
62 | $9,716 | |
| 8 | AZN |
Astrazeneca PLC
|
40 | $7,584 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,189,870 | 9,418 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,292,378 | 9,273 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,131,294 | 9,217 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,016,649 | 9,159 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,008,362 | 9,095 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,011,587 | 9,028 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $828,004 | 8,964 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $745,505 | 8,892 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $609,737 | 8,887 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $638,227 | 8,713 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $698,468 | 8,622 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $640,137 | 8,542 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $651,858 | 8,458 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $694,956 | 8,376 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $712,469 | 8,299 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $507,523 | 8,227 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $502,762 | 8,134 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $477,978 | 8,040 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $576,741 | 7,943 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $549,509 | 7,867 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $536,281 | 7,788 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $498,168 | 7,708 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $327,712 | 5,625 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $351,273 | 5,559 | Shares | Sole | 2020-10-15 | |
| No filing history on record for this holder in this stock. | ||||||